*NEW* - Principles for PLHIV Prioritisation for COVID-19 Vaccination – Regional recommendations


ASHM’s BBVs, Sexual Health and COVID-19 Regional Advisory Group (RAG) was established in March 2020. It provides a timely opportunity for the HIV, sexual health and viral hepatitis sectors to discuss the scientific, clinical, HIV, sexual health and viral hepatitis service delivery and social implications of COVID-19 and provides consistent and evidence-based messaging to the health workforce, sector partners and community. The RAG is the regional arm of the Taskforce on BBVs, Sexual Health and COVID-19.

Below you can find the various outputs of the RAG, information about its structure and membership and links to ASHM and external resources in the context of COVID-19. Bulletins from the Taskforce/RAG are issued weekly on Thursdays, as well as urgent updates when deemed relevant to the sector. If you want to provide feedback or have any questions regarding the Regional Advisory Group please email taskforce.rag@ashm.org.au.

Disclaimer: Guidance provided by the Regional Advisory Group is not intended to replace national guidance.


Please see all members of the Regional Advisory Group here.


The COVID-19 pandemic is affecting the availability and accessibility of sexual and reproductive health and rights (SRHR) services worldwide. Please see the ISRHR Consortium Statement on COVID-19 and SRHR.


BBV, Sexual Health and COVID-19 Regional Advisory Group Evaluation 2020



Clinical care


Science and Research


Priority populations